Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients

Surgical Neurology

Volumn 68, Issue 5 SUPPL., 2007, Pages

  Lee, Han Chung ^a   Cho, Der Yang ^a   Lee, Wen Yuan ^a   Chuang, Hao Che ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute spinal cord injury; EMT; Methylprednisolone; NASCIS; Tracheostomy

Indexed keywords

METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PEPTIC ULCER; SCHOOL CHILD; SENSORY EVALUATION; SEPSIS; SPINAL CORD DECOMPRESSION; SPINAL CORD INJURY; SURVIVAL RATE; TRACHEOSTOMY; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL VERTEBRAE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS; TRACHEOSTOMY; TREATMENT OUTCOME;

EID: 35348960393     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.06.085     Document Type: Article

References (29)

1. Amar P.A., and Levy M.L. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44 (1999) 1027-1040
2. Bracken M.B., Collins W.F., Freeman D.F., et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251 1 (1984) 45-52
3. Bracken M.B., Shepard M.J., Collins W.F., et al. A randomized, controlled trial of methylprednisolone and naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322 20 (1990) 1405-1411
4. Bracken M.B., Shepard M.J., Holford T.R., et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277 20 (1997) 1597-1604
5. Bracken M.B., Shepard M.J., Holford T.R., et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury Randomized Controlled Trial. J Neurosurg 89 5 (1998) 699-706
6. Basu S., Hellberg A., Ulus A.T., Westman J., and Karacagil S. Biomarkers of free radical injury during spinal cord ischemia. FEBS Lett 508 1 (2001) 36-38
7. Brian K.K., and Wolfram T. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4 (2004) 451-464
8. Cuzzocrea S., Riley D.P., Caputi A.P., and Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53 1 (2001) 135-159
9. Del M., Bigio R., and Johnson G.E. Clinical presentation of spinal cord concussion. Spine 14 1 (1989) 37-40
10. Ducker T.B., and Hamit H.F. Experimental treatments of acute spinal cord injury. J Neurosurg 30 6 (1969) 693-697
11. Ducker T.B., and Zeidman S.M. Spinal cord injury. Role of steroid therapy. Spine 19 20 (1994) 2281-2287
12. Gerhart K. A. Spinal cord injury outcomes in a population-based sample. J Trauma 31 (1991) 1529
13. +-ATPase and lipid peroxidation. J Neurosurg 62 5 (1985) 743-749
14. Klusman I., and Schwab M.E. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res 762 1-2 (1997) 173-184
15. Lou J., Lenke L.G., Xu F., and O'Brien M. In vivo Bcl-2 oncogene neuronal expression in the rat spinal cord. Spine 23 5 (1998) 517-523
16. Apuzzo M.L.J. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery 50 3 Suppl (2002) S63-S72
17. Matsumoto T., Tamaki T., and Kawakami M. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine 26 (2001) 426-430
18. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 45 6 (1998) 1088-1093
19. Nicholson D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407 6805 (2000) 810-816
20. Ng A., and Smith G. Gastroesophageal reflux and aspiration of gastric contents in anesthetic practice. Anesth Analg 93 (2001) 494-513
21. Piepmeier J.M., and Jenkins N.R. Late neurological changes following traumatic spinal cord injury. J Neurosurg 69 (1988) 399
22. Rosenberg L.J., and Wrathall J.R. Time course studies on the effectiveness of tetrodotoxin in reducing consequences of spinal cord contusion. J Neurosci Res 66 2 (2001) 191-202
23. Tator C.H., and Koyanagi I. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 86 3 (1997) 483-492
24. Tator C.H. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 42 (1998) 696-708
25. Qian T., Campagnolo D., and Kirshblum S. High-dose methylprednisolone may do more harm for spinal cord injury. Med Hypotheses 55 5 (2000) 452-453
26. Wrathall J.R., Teng Y.D., and Choiniere D. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp Neurol 137 1 (1996) 119-126
27. Young W., and Bracken M.B. The Second National Acute Spinal Cord Injury Study. J Neurotrauma 9 Suppl 1 (1992) S397-S405
28. Zwimpfer T.J., and Bernstein M. Spinal cord concussion. J Neurosurg 72 6 (1990) 894-900
29. Zeidman S.M., Ling G.S., Ducker T.B., and Ellenbogen R.G. Clinical applications of pharmacologic therapies for spinal cord injury. J Spinal Disord 9 (1996) 367-380